| Home > Publications Database > Gene expression profiles of carotid plaques differ between patients with amaurosis fugax and those with cerebral transient ischaemic attack or stroke. |
| Journal Article | DZNE-2026-00883 |
; ; ; ; ; ; ; ; ; ; ; ; ; ;
2026
Oxford University Press
Oxford
This record in other databases:
Please use a persistent id in citations: doi:10.1093/cvr/cvag116
Abstract: In patients with atherosclerotic internal carotid artery stenosis, the risk of subsequent ischaemic stroke is higher in those presenting with a cerebral transient ischaemic attack (TIA) than in those with amaurosis fugax (AFX; transient monocular blindness). While AFX is associated with more stable histological characteristics, the underlying molecular mechanisms remain unclear. We hypothesized that biological processes and gene expression profiles in carotid plaques of patients with AFX differ from those with cerebral TIA and stroke.We analysed carotid plaques from 2508 patients undergoing endarterectomy between 2002 and 2022. Bulk RNA sequencing (RNA-seq) was performed on 1088 plaques (136 asymptomatic, 179 AFX, 481 TIA, 292 stroke). Single-cell RNA-seq from 46 previously profiled plaques was used to identify cell-specific transcriptomic signatures. Mass spectrometry-based proteomics (n = 189) and targeted plasma proteomics (n = 1291) were used to validate the molecular differences. AFX plaques showed fewer lipid-rich cores than those from cerebral TIA [odds ratio (95% CI): 1.41 (1.03-1.94)] or stroke [1.42 (1.01-1.99)]. RNA-seq identified 408 differentially expressed genes (DEGs) between AFX and TIA and 463 between AFX and stroke (FDR < 0.1), while AFX and asymptomatic plaques showed only 10 DEGs. AFX plaques were enriched for vascular smooth muscle cell signatures and extracellular matrix remodelling, while cerebral TIA and stroke plaques exhibited macrophage-driven inflammatory molecular signatures. These transcriptomic differences were confirmed by plaque proteomic analyses. In parallel, circulating proteomic profiling revealed higher levels of inflammatory and thrombo-inflammatory markers in cerebral TIA and stroke compared with AFX.AFX plaques exhibit stable, SMC-dominant molecular signatures that differ markedly from the macrophage-driven inflammatory profiles of cerebral TIA and stroke plaques. These findings support AFX as a biologically distinct entity with potential implications for risk stratification and personalized treatment.
Keyword(s): Humans (MeSH) ; Amaurosis Fugax: genetics (MeSH) ; Amaurosis Fugax: diagnosis (MeSH) ; Ischemic Attack, Transient: genetics (MeSH) ; Ischemic Attack, Transient: diagnosis (MeSH) ; Ischemic Attack, Transient: metabolism (MeSH) ; Female (MeSH) ; Male (MeSH) ; Plaque, Atherosclerotic (MeSH) ; Carotid Stenosis: genetics (MeSH) ; Carotid Stenosis: surgery (MeSH) ; Carotid Stenosis: pathology (MeSH) ; Carotid Stenosis: complications (MeSH) ; Carotid Stenosis: metabolism (MeSH) ; Aged (MeSH) ; Transcriptome (MeSH) ; Risk Factors (MeSH) ; Middle Aged (MeSH) ; Stroke: genetics (MeSH) ; Risk Assessment (MeSH) ; Gene Expression Profiling (MeSH) ; RNA-Seq (MeSH) ; Single-Cell Gene Expression Analysis (MeSH) ; Amaurosis fugax ; Atherosclerosis ; Carotid plaque ; Multi-omics ; Transient ischaemic attack
|
The record appears in these collections: |